Sonoma Pharmaceuticals Inc. (SNOA) concluded trading on Wednesday at a closing price of $0.19, with 52.57 million shares of worth about $9.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -82.54% during that period and on Wednesday, January 31 the price saw a gain of about 19.19%. Currently the company’s common shares owned by public are about 13.68M shares, out of which, 13.46M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 2 times over the past 12 months. They bought 200,000 shares in 2 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stock saw a price change of 11.24% in past 5 days and over the past one month there was a price change of 2.61%. Year-to-date (YTD), SNOA shares are showing a performance of 2.61% which decreased to -89.05% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.12 but also hit the highest price of $1.92 during that period. The average intraday trading volume for Sonoma Pharmaceuticals Inc. shares is 1.64 million. The stock is currently trading 3.37% above its 20-day simple moving average (SMA20), while that difference is up 4.94% for SMA50 and it goes to -73.79% lower than SMA200.
Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) currently have 13.68M outstanding shares and institutions hold larger chunk of about 0.92% of that.
The stock has a current market capitalization of $2.53M and its 3Y-monthly beta is at 1.32. It has posted earnings per share of -$1.48 in the same period. It has Quick Ratio of 2.70 while making debt-to-equity ratio of 0.09. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SNOA, volatility over the week remained 34.24% while standing at 20.30% over the month.
Analysts are in expectations that Sonoma Pharmaceuticals Inc. (SNOA) stock would likely to be making an EPS of -$0.21 in the current quarter, while forecast for next quarter EPS is -$0.17 and it is -$0.45 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.21 which is -$0.21 at the higher side of the target for the same.
